Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4651–4700 of 18639
Cathy W. Liles, age 59, the Company’s Chief Accounting Officer & Senior Vice President, has been named Interim Chief Financial Officer.
On July 15, 2024, the Board appointed Mr. Kenneth R. Bull, the Chief Operating Officer of the Company, to also serve as the Company’s President and Chief Executive Officer on an interim basis while the Company conducts a search for Mr. Anderson’s permanent replacement.
On July 15, 2024, Joel D. Anderson, President and Chief Executive Officer of Five Below, Inc. (the “Company”), notified the Company’s Board of Directors (the “Board”) that he was resigning as President and Chief Executive Officer and a member of the Board effective immediately.
She was promoted to CEO, CFO and Chairman of the Board as a part of their succession plan, which was created due to the failing health of Mr. John Poss.
Mr. Poss had battled through serious health issues and had served the company very well since 2015. Fortunately, Mr. Poss had spent years preparing Dr. Small-Howard for her expanded role as CEO, CFO and Chairman, which roles fell to her upon the passing of Mr. Poss on July 10, 2024.
On June 15, 2024, Jeffery Cauble, the Chief Financial Officer of ThermoGenesis Holdings, Inc. (the “Company”), resigned as an employee and officer of the Company.
On July 16, 2024, the Board of Directors (the “Board”) of ChromaDex Corporation (the “Company” or “ChromaDex”) appointed James Lee, the Company’s current Controller, as the Company’s Interim Chief Financial Officer and Interim Principal Accounting Officer, effective as of July 13, 2024.
As previously disclosed, Brianna Gerber resigned from her roles as the Company’s Chief Financial Officer and Principal Accounting Officer effective July 12, 2024.
Richard Hume, the Company’s current President and Chief Executive Officer, will retire from the Company but remain on the Company’s Board of Directors.
effective September 1, 2024, Patrick Zammit, the Company’s Executive Vice President, Chief Operating Officer, will be appointed President and Chief Executive Officer
Terry-Ann Burrell notified Beam Therapeutics Inc. (the “Company”) of her decision to resign as Chief Financial Officer and Treasurer of the Company, effective August 9, 2024, to pursue other opportunities.
On July 15, 2024, the Company announced the appointment of R. David Rosato as its Chief Financial Officer. Mr. Rosato is expected to commence his role with the Company effective August 1, 2024.
James B. Fitzgerald, the principal financial officer of the Company, notified the Company’s Chief Executive Officer and the Audit Committee of its Board of Directors on April 24, 2024, that he planned to transition from his roles as Chief Financial Officer, Chief Administrative Officer and Treasurer of the Company effective upon the appointment and commencement of employment of his successor.
Jean-Marc Gilson was appointed as the President, Chief Executive Officer and Director of the General Partner.
Jean-Marc Gilson was appointed as the President and Chief Executive Officer of the Company.
effective upon the previously announced retirement of Glenn MacInnes from his position as Executive Vice President and Chief Financial Officer of the Company and the Bank, which is expected in August 2024.
The Board of Directors also appointed Mr. Holland as the Chief Financial Officer of the Company and the Bank, effective upon the previously announced retirement of Glenn MacInnes from his position as Executive Vice President and Chief Financial Officer of the Company and the Bank, which is expected in August 2024.
following an approximately 60-day transition with Veeva board member and interim CFO, Tim Cabral.
Brian Van Wagener will become Veeva’s chief financial officer (“CFO”) following an approximately 60-day transition with Veeva board member and interim CFO, Tim Cabral.
On July 11, 2024, the Company and Robin Ross entered into an employment agreement (the “Ross Employment Agreement”), effective as of July 11, 2024 (the “Ross Employment Agreement Effective Date”), pursuant to which Mr. Ross will serve as Chief Executive Officer of the Company, replacing Mr. Peterson, and will also continue to serve as the Chairman of the Board.
On July 9, 2024, Michael L. Peterson delivered to the Board of Directors (“Board”) of Trio Petroleum Corp. (the “Company”) a notice of his resignation as the Company’s Chief Executive Officer and a member of the Board, effective on July 11, 2024 (the “Resignation Effective Date”).
Mr. Hisey, the current interim CEO of the Company, was reappointed as Chief Financial Officer (the “CFO”).
On July 15, 2024, Envista Holdings Corporation (the “Company”) announced that it has appointed Eric Hammes as the Senior Vice President and Chief Financial Officer of the Company, with such appointment to be effective as of August 8, 2024.
the Board appointed Jay Jennings, the Company’s Chief Financial Officer, to serve as the Acting Chief Executive Officer of the Company effective upon the termination of Mr. Beck as Chief Executive Officer.
On July 10, 2024, Martin Beck submitted a letter of resignation to the Chairman of the Board of Directors (the “Board”) of UpHealth, Inc. (the “Company”) from his positions as the Chief Executive Officer of the Company and all subsidiaries of the Company for which he serves as Chief Executive Officer.
the Board appointed Mr. Honjian as President/CEO and CFO and as Secretary
the Board appointed Mr. Honjian as President/CEO and CFO and as Secretary
the Company’s President and Chief Executive Officer (“CEO”) Kevin P. Riley will be retiring and a search has been initiated for his successor.
named Vikram Grover as our CEO, Treasurer & Secretary adding to his CFO title.
we removed Ryan Nguyen as CEO and Director for cause and named Vikram Grover as our CEO, Treasurer & Secretary adding to his CFO title.
Effective as of Mr. Suidan’s departure, Brad Ramberg, the Company’s Executive Vice President – Strategic Initiatives, will be appointed Interim Chief Financial Officer
On July 12, 2024, Marc Suidan, the Chief Financial Officer of The Beachbody Company, Inc. (the “Company”) informed the Company of his decision to resign from his position, effective August 15, 2024 to pursue other business opportunities.
On July 8, 2024, Mr. Yuhua Huang resigned as a Chief Financial Officer of Wetouch Technology Inc. (the “Company”).
On July 8, 2024. the Board of Company appointed Xing Tang to serve as the Chief Financial Officer of the Company, effective July 8, 2024.
On the same date, the Company appointed Michael J. Logozzo, the Company’s Chief Operating Officer and President, to serve as its interim Chief Financial Officer (and principal financial and accounting officer), effective immediately.
On July 12, 2024, reAlpha Tech Corp. (the “Company”) terminated the employment of Michael Frenz as the Company’s Chief Financial Officer (and principal financial and accounting officer), effective immediately.
the Board unanimously appointed Dr. Prasad A. Jeereddi, age 76, Chief Executive Officer of the Company
Chandra Patel resigned from his positions as GPAC II’s Chief Executive Officer and Chairman
Roshan Pujari, as Chief Executive Officer
Udaychandra Devasper, as Chief Financial Officer
Jarett Goldman resigned from his position as GPAC II’s Chief Financial Officer
On July 10, 2024 , the Company’s Board of Directors appointed Mr. Richard B. Leeds, the Executive Chairman of the Board, to serve as Chief Executive Officer on an interim basis effective August 9, 2024.
On July 10, 2024 , Barry Litwin, Chief Executive Officer of Global Industrial Company (the “Company”), notified the Company that he was resigning as Chief Executive Officer and a member of the Board of Directors of the Company effective August 9, 2024.
effective as of July 12, 2024, the effective date of Mr. Tsoumas’s retirement.
On July 8, 2024, the Board appointed Mr. Rawden to the office of Interim Chief Financial Officer effective as of July 12, 2024, the effective date of Mr. Tsoumas’s retirement.
On July 5, 2024, Mariela Matute, Executive Vice President & Chief Financial Officer of Tupperware Brands Corporation (the “Company”), informed the Company of her intention to resign from her position, effective July 31, 2024.
On July 11, 2024, Olaplex Holdings, Inc. (the “Company”) announced that the Company intends to appoint Catherine Dunleavy, age 55, as Chief Operating Officer (“COO”) and Chief Financial Officer (“CFO”) of the Company, effective as of August 13, 2024.
On July 8, 2024, Dr. Alan K. Hauser, Ph.D. was appointed as Chief Executive Officer of Health Discovery Corporation
Following an extensive search, the Board of Directors hired Dr. Hauser to replace George McGovern, the former Chief Executive Officer of the Company.
Effective July 15, 2024, Gordon Brooks, age 55, group vice president, controller and corporate strategy, of the Company, will assume the role of interim chief financial officer of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.